Literature DB >> 14574038

Atrial fibrillation: what are the targets for intervention?

John M Miller1, Jeffrey E Olgin, Mithilesh K Das.   

Abstract

Atrial fibrillation (AF) is a difficult and growing problem in the population. While medical therapy controls symptoms in many patients, a proportion of individuals with this common arrhythmia cannot be optimally managed with drugs alone. However, truly curative therapy for AF has always been one of the "holy grails" of electrophysiology. The surgical maze procedure was the first to offer permanent maintenance of sinus rhythm in patients with AF but subjected the patient to open heart surgery; a catheter-based translation of the maze procedure served as proof of concept that a catheterization technique could be used to treat AF. Subsequent experience has narrowed the electrophysiologist's attention to ablation of triggers of AF, most often residing in the pulmonary veins, rather than requiring more extensive ablation lines to control the arrhythmia. The following discussion deals with the development and current status of techniques for catheter ablation of atrial fibrillation, focusing on determination of appropriate target sites for ablation.

Entities:  

Mesh:

Year:  2003        PMID: 14574038      PMCID: PMC1995673          DOI: 10.1023/a:1026332426999

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  32 in total

1.  Architecture of the pulmonary veins: relevance to radiofrequency ablation.

Authors:  S Y Ho; J A Cabrera; V H Tran; J Farré; R H Anderson; D Sánchez-Quintana
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

2.  Left atrial appendage activity masquerading as pulmonary vein potentials.

Authors:  Dipen Shah; Michel Haissaguerre; Pierre Jais; Meleze Hocini; Teiichi Yamane; Laurent Macle; Kee Joon Choi; Jacques Clementy
Journal:  Circulation       Date:  2002-06-18       Impact factor: 29.690

3.  Pulmonary vein isolation: comparison of bipolar and unipolar electrograms at successful and unsuccessful ostial ablation sites.

Authors:  Hiroshi Tada; Hakan Oral; Kristina Wasmer; Radmira Greenstein; Frank Pelosi; Bradley P Knight; S Adam Strickberger; Fred Morady
Journal:  J Cardiovasc Electrophysiol       Date:  2002-01

4.  Pulmonary vein isolation by circumferential radiofrequency lesions in atrial fibrillation. From substrate to clinical outcome.

Authors:  C Pappone; V Santinelli
Journal:  Ann Ist Super Sanita       Date:  2001       Impact factor: 1.663

5.  Electrogram polarity reversal as an additional indicator of breakthroughs from the left atrium to the pulmonary veins.

Authors:  Teiichi Yamane; Dipen C Shah; Pierre Jaïs; Mélèze Hocini M; Isabel Deisenhofer; Kee-Joon Choi; Laurent Macle; Jacques Clémenty; Michel Haïssaguerre
Journal:  J Am Coll Cardiol       Date:  2002-04-17       Impact factor: 24.094

6.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

7.  Myocardium extending from the left atrium onto the pulmonary veins: a comparison between subjects with and without atrial fibrillation.

Authors:  M Tagawa; K Higuchi; M Chinushi; T Washizuka; T Ushiki; N Ishihara; Y Aizawa
Journal:  Pacing Clin Electrophysiol       Date:  2001-10       Impact factor: 1.976

8.  Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation.

Authors:  Hakan Oral; Bradley P Knight; Mehmet Ozaydin; Hiroshi Tada; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094

9.  Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies.

Authors:  Nassir F Marrouche; Thomas Dresing; Christopher Cole; Dianna Bash; Eduardo Saad; Krzysztof Balaban; Stephen V Pavia; Robert Schweikert; Walid Saliba; Ahmed Abdul-Karim; Ennio Pisano; Raffaele Fanelli; Patrick Tchou; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2002-08-07       Impact factor: 24.094

10.  Dilatation as a marker of pulmonary veins initiating atrial fibrillation.

Authors:  Teiichi Yamane; Dipen C Shah; Pierre Jaïs; Mélèze Hocini; Jing Tian Peng; Isabel Deisenhofer; Jacques Clémenty; Michel Haïssaguerre
Journal:  J Interv Card Electrophysiol       Date:  2002-07       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.